Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Recursion Pharmaceuticals, Inc. (RXRX : NSDQ)
 
 • Company Description   
Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

Number of Employees: 331

 
 • Price / Volume Information   
Yesterday's Closing Price: $17.72 Daily Weekly Monthly
20 Day Moving Average: 1,324,741 shares
Shares Outstanding: 168.99 (millions)
Market Capitalization: $2,994.56 (millions)
Beta:
52 Week High: $42.81
52 Week Low: $15.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -9.22% -6.39%
12 Week -38.54% -39.15%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
41S RIO GRANDE STREET
-
SALT LAKE CITY,UT 84101
USA
ph: 385-269-0203
fax: 801-821-2872
investorrelations@recursion.com http://www.recursion.com
 
 • General Corporate Information   
Officers
Christopher Gibson - Chief Executive Officer
R. Martin Chavez - Chairman
Tina Marriott Larson - Chief Operating Officer and President
Michael Secora - Chief Financial Officer
Zachary Bogue - Director

Peer Information
Recursion Pharmaceuticals, Inc. (GSAC)
Recursion Pharmaceuticals, Inc. (CASI)
Recursion Pharmaceuticals, Inc. (ALCD.)
Recursion Pharmaceuticals, Inc. (OMNN)
Recursion Pharmaceuticals, Inc. (CGPI.)
Recursion Pharmaceuticals, Inc. (ISR)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 75629V104
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/09/22
Share - Related Items
Shares Outstanding: 168.99
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $2,994.56 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.29 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.37 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 25.02% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 5.00
Price/Cash Flow: -
Price / Sales: 289.72
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 9.68%
Sales Growth
vs. Year Ago Period: 147.22%
vs. Previous Quarter: -0.59%
ROE
09/30/21 - -73.43
06/30/21 - -243.38
03/31/21 - -
ROA
09/30/21 - -30.57
06/30/21 - -39.01
03/31/21 - -69.62
Current Ratio
09/30/21 - 13.99
06/30/21 - 21.92
03/31/21 - 8.26
Quick Ratio
09/30/21 - 13.99
06/30/21 - 21.92
03/31/21 - 8.26
Operating Margin
09/30/21 - -1,425.23
06/30/21 - -1,402.03
03/31/21 - -1,536.19
Net Margin
09/30/21 - -1,425.23
06/30/21 - -1,402.03
03/31/21 - -1,536.19
Pre-Tax Margin
09/30/21 - -1,425.23
06/30/21 - -1,402.03
03/31/21 - -1,536.19
Book Value
09/30/21 - 3.54
06/30/21 - 3.82
03/31/21 - -9.69
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - 0.00
06/30/21 - 0.01
03/31/21 - -
Debt-to-Capital
09/30/21 - 0.11
06/30/21 - 1.44
03/31/21 - 4.58
 

Powered by Zacks Investment Research ©